Skip to content

Clinical Investigation of Wysa

Real World Testing of an Artificial Intelligence-enabled App as an Early Intervention and Support Tool in the Mental Health Referral Care Pathway

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05533190
Enrollment
76
Registered
2022-09-08
Start date
2022-12-13
Completion date
2023-07-25
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depressive Symptoms, Mental Health Issue

Keywords

Artificial Intelligence, Mental Health, Telemedicine, Conversational Agent

Brief summary

Mental health concerns are a large burden for individuals, healthcare systems, and the economy. Over a million people are referred to UK mental health services each year, but more than half only receive one session of workbook-based support. Many others have to wait over 12 weeks for assessment and treatment. Wysa is a digital health app with over 3 million users that uses an artificial intelligence (AI) chatbot and a series of self-care exercises to provide mental health support and to help people develop strategies to manage their mental health and improve their resilience. This project aims to examine the impact of using Wysa on patients' symptoms of anxiety and depression during the referral process for standard UK mental health services. Patients will be given access to Wysa at the point of referral to the Improving Access to Psychological Therapies (IAPT) programme and can begin to explore the self-support tools, while they are on the waitlist for assessment and treatment. The investigators will gather a group of patients and members of the public to contribute to the recruitment of patients for the study, the methods we use to evaluate Wysa, and to provide insights on how best to share the results of our study with the general public. The investigators will use the standard IAPT measures of anxiety and depression to look at the effect of using Wysa patients' mental well-being. These questionnaires will be provided through the app and the results will be compared with a waitlist control group. The investigators will examine whether Wysa can identify people who are experiencing severe mental health difficulties so that they can be provided with additional support. Users' levels of engagement with Wysa will be assessed and some participants will be randomly selected to do an interview so the investigators can get a better understanding of what people liked and disliked about using the app and why. Finally, the investigators will be evaluating the cost-effectiveness of Wysa compared with usual care. The investigators expect that the study will show that Wysa helps reduce symptoms of anxiety and depression in people who are on the waiting list for IAPT. If the study shows this positive impact, this will provide evidence to support the use of Wysa to improve the accessibility of mental health support in clinical pathways. The investigators will be publishing the results of our study in academic journals as well as in more generally accessible platforms.

Interventions

DEVICEWysa AI chatbot mental health app

Wysa is a guided self-help and triaging tool delivered to patients via an app. It includes a chatbot and makes use of a wide range of clinically underpinned modules to provide mental health support.

Sponsors

Institute of Cancer Research, United Kingdom
CollaboratorOTHER
Imperial College London
CollaboratorOTHER
University of Warwick
CollaboratorOTHER
University of Oxford
CollaboratorOTHER
University of Plymouth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Due to the nature of the intervention, no blinding of participants will be possible in the study, as all participants will know whether or not they are using the app. Clinical treatment teams will also not be blinded as they will know through the electronic patient record if a participant has received the intervention. The evaluation team will be blinded to treatment using the randomisation algorithm.

Intervention model description

Participants will be randomly allocated to the intervention condition or a standard care waitlist control condition.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Willing and able to provide informed consent; * Aged 18 years or older; * Ability to speak English to a secondary school standard; * Own a mobile device capable of supporting Wysa; * A valid email address; * Referred or self-referred to proceed through the standard IAPT care pathway.

Exclusion criteria

* Patients ineligible for the standard IAPT care pathway; * Patients with previous and current known major mental illness such as Schizophrenia, severe depression, any co-morbid neurological or neuro-psychiatric condition such as epilepsy; * Patients with current psychosis or a history of psychotic symptoms within the last 6 months; * Patients with suicidal ideation; * Patients scoring \> 15 points on PHQ 9; * Patients scoring \> 15 points on GAD-7; * Patients with significant cognitive disorders; * Patients with noted neurodevelopmental conditions such as autism or ADHD; * Patients previously diagnosed with a personality disorder; * Patients who been under the care of CMHT or a specialised mental health services in the last 2 years; * Patients who failed IAPT previously; * Patients with referrals for specialist presentations of pre-existing, diagnosed conditions requiring a specialised assessment beyond the standard clinical pathway; * Incapable of self-consent; * In a dependent/unequal relationship with the research or care teams or any PPI representatives.

Design outcomes

Primary

MeasureTime frameDescription
Depression Severity3 months post-randomisationScore on the PHQ-9, total scores range from 0 to 27 (higher scores indicated more severe depression)

Secondary

MeasureTime frameDescription
Crisis Identification3 months post-randomisationPlanned to compare number of users identified by the app for escalation of care compared to the number of patients in the control group who access A&E or out-of-hours services while waiting for treatment; this was not possible, data reported reflect risk events triggered by Wysa or the participant in-app
Uptake Rates3 months post-randomisationUptake rates of participants randomised into intervention group
Dropout Rates3 months post-randomisationDropout rates of participants who are randomised into intervention group and start using the app
Use of the App3-7 months post-randomisationParticipant engagement with the app (whether it was used at all based on app usage data)
Engagement3-7 months post randomisationQualitative feedback from semi-structured interviews about engagement with the app
Anxiety Severity3 months post-randomisationScore on the GAD-7, total scores range from 0 to 21 (higher scores indicated more severe anxiety)
General Health StateMeasured at baseline and 3 months post-randomisation5-level EQ-5D version (EQ-5D-5L) which measures health-related quality of life via 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and a visual scale - total survey scores were calculated and can range from 5 to 125 (higher scores indicate more severe health problems). A single index was obtained by transforming the ordinal survey responses using the 'eq5d' package in R. Range: The EQ-5D index score typically ranges from -0.594 to 1 (depending on the country-specific value set used). Interpretation: 1.000 represents full health (the best possible outcome). 0.000 represents a health state equivalent to death (neutral point). Negative values (e.g., -0.594) indicate health states perceived as worse than death. Higher index values indicate better health outcomes, while lower values represent poorer health states. https://euroqol.org/wp-content/uploads/2023/11/EQ-5D-5LUserguide-23-07.pdf
Type of App Usage - Exercises Completed3 months post-randomisationFrequency and duration of app use
Type of App Usage - Sessions Completed3 months post-randomisationFrequency and duration of app use
Type of App Usage - Messages to Chatbot3 months post-randomisationFrequency and duration of app use
Patient Perceptions of Acceptability3-7 months post randomisationQualitative feedback from semi-structured interviews about the acceptability of the app

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Wysa AI Chatbot Mental Health App
Wysa is a guided self-help and triaging tool delivered to patients via an app or widget. It uses Natural Language Processing to understand individuals' written inputs but not to generate responses. Wysa makes use of a wide range of clinically underpinned modules whilst gamification, clinical outcome measures and AI promotes engagement, improving efficacy and triage and reducing the cost of scale. Wysa AI chatbot mental health app: Wysa is a guided self-help and triaging tool delivered to patients via an app. It includes a chatbot and makes use of a wide range of clinically underpinned modules to provide mental health support.
30
Waitlist Control
The intervention will be compared against a waitlist group. This comparator was selected to compare Wysa to the current standard of care for patients waiting for standard IAPT assessment and treatment.
16
Total46

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyFailed to download app10
Overall StudyLost to Follow-up197
Overall StudyThought app was a scam10
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicWysa AI Chatbot Mental Health AppWaitlist ControlTotal
Age, Continuous36.0 years
STANDARD_DEVIATION 14.4
37.1 years
STANDARD_DEVIATION 15.8
36.3 years
STANDARD_DEVIATION 14.7
GAD-711.3 units on a scale
STANDARD_DEVIATION 4.92
11.9 units on a scale
STANDARD_DEVIATION 4.92
11.5 units on a scale
STANDARD_DEVIATION 4.87
PHQ-911.9 units on a scale
STANDARD_DEVIATION 5.07
11.0 units on a scale
STANDARD_DEVIATION 4.38
11.6 units on a scale
STANDARD_DEVIATION 4.81
Race/Ethnicity, Customized
Asian or Asian British
3 Participants1 Participants4 Participants
Race/Ethnicity, Customized
Black or Black British
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Not known
1 Participants2 Participants3 Participants
Race/Ethnicity, Customized
Other ethnic groups
4 Participants5 Participants9 Participants
Race/Ethnicity, Customized
White
21 Participants8 Participants29 Participants
Sex/Gender, Customized
Declined to respond
1 Participants0 Participants1 Participants
Sex/Gender, Customized
Female
18 Participants11 Participants29 Participants
Sex/Gender, Customized
Male
10 Participants4 Participants14 Participants
Sex/Gender, Customized
Transgender female
1 Participants1 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 16
other
Total, other adverse events
5 / 300 / 16
serious
Total, serious adverse events
0 / 300 / 16

Outcome results

Primary

Depression Severity

Score on the PHQ-9, total scores range from 0 to 27 (higher scores indicated more severe depression)

Time frame: 3 months post-randomisation

ArmMeasureValue (MEAN)Dispersion
Wysa AI Chatbot Mental Health AppDepression Severity9.28 units on a scaleStandard Deviation 6.56
Waitlist ControlDepression Severity8.41 units on a scaleStandard Deviation 3.82
Secondary

Anxiety Severity

Score on the GAD-7, total scores range from 0 to 21 (higher scores indicated more severe anxiety)

Time frame: 3 months post-randomisation

ArmMeasureValue (MEAN)Dispersion
Wysa AI Chatbot Mental Health AppAnxiety Severity8.98 units on a scaleStandard Deviation 6.13
Waitlist ControlAnxiety Severity8.19 units on a scaleStandard Deviation 3.22
Secondary

Crisis Identification

Planned to compare number of users identified by the app for escalation of care compared to the number of patients in the control group who access A&E or out-of-hours services while waiting for treatment; this was not possible, data reported reflect risk events triggered by Wysa or the participant in-app

Time frame: 3 months post-randomisation

Population: Waitlist control group was not analysed for Users triggered in-app escalation or App identified and flagged suicidal language because these participants did not have access to the app

ArmMeasureGroupValue (NUMBER)
Wysa AI Chatbot Mental Health AppCrisis IdentificationUsers triggered in-app escalation4 participants
Wysa AI Chatbot Mental Health AppCrisis IdentificationApp identified and flagged suicidal language1 participants
Wysa AI Chatbot Mental Health AppCrisis IdentificationSelf-reports to the service or crisis service reports (iaptus record)0 participants
Waitlist ControlCrisis IdentificationSelf-reports to the service or crisis service reports (iaptus record)0 participants
Secondary

Dropout Rates

Dropout rates of participants who are randomised into intervention group and start using the app

Time frame: 3 months post-randomisation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Wysa AI Chatbot Mental Health AppDropout Rates23 Participants
Waitlist ControlDropout Rates7 Participants
Secondary

Engagement

Qualitative feedback from semi-structured interviews about engagement with the app

Time frame: 3-7 months post randomisation

Population: Participants in the Wysa group who completed semi-structured interviews - the numbers reported are counts of the number of participants who expressed a particular theme generated from the thematic analysis

ArmMeasureGroupValue (NUMBER)
Wysa AI Chatbot Mental Health AppEngagementMinimal transfer of skills beyond app4 participants
Wysa AI Chatbot Mental Health AppEngagementReminders helped prompt use but app was easy to ignore4 participants
Wysa AI Chatbot Mental Health AppEngagementVarying patterns of use for individuals4 participants
Wysa AI Chatbot Mental Health AppEngagementDecrease in use over time2 participants
Secondary

General Health State

5-level EQ-5D version (EQ-5D-5L) which measures health-related quality of life via 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and a visual scale - total survey scores were calculated and can range from 5 to 125 (higher scores indicate more severe health problems). A single index was obtained by transforming the ordinal survey responses using the 'eq5d' package in R. Range: The EQ-5D index score typically ranges from -0.594 to 1 (depending on the country-specific value set used). Interpretation: 1.000 represents full health (the best possible outcome). 0.000 represents a health state equivalent to death (neutral point). Negative values (e.g., -0.594) indicate health states perceived as worse than death. Higher index values indicate better health outcomes, while lower values represent poorer health states. https://euroqol.org/wp-content/uploads/2023/11/EQ-5D-5LUserguide-23-07.pdf

Time frame: Measured at baseline and 3 months post-randomisation

Population: Not all participants completed the follow-up assessment

ArmMeasureGroupValue (MEAN)Dispersion
Wysa AI Chatbot Mental Health AppGeneral Health StateBaseline0.681 units on a scaleStandard Deviation 0.163
Wysa AI Chatbot Mental Health AppGeneral Health State12 weeks0.688 units on a scaleStandard Deviation 0.174
Waitlist ControlGeneral Health StateBaseline0.607 units on a scaleStandard Deviation 0.235
Waitlist ControlGeneral Health State12 weeks0.644 units on a scaleStandard Deviation 0.192
Secondary

Patient Perceptions of Acceptability

Qualitative feedback from semi-structured interviews about the acceptability of the app

Time frame: 3-7 months post randomisation

Population: Participants in the Wysa group who completed semi-structured interviews - the numbers reported are counts of the number of participants who expressed a particular theme generated from the thematic analysis

ArmMeasureGroupValue (NUMBER)
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityApp did not meet all needs; not long-term solution or replacement for therapy4 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityEasy to use but a bit overwhelming4 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityTone affected user connection with app3 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityTool was exciting and a relief because of accessible support and expected benefit4 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityTrustworthiness shaped by source credibility and personal experience4 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityLimited chatbot frustrated users4 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilityRange of resources were useful for users4 participants
Wysa AI Chatbot Mental Health AppPatient Perceptions of AcceptabilitySuggestions for improvement3 participants
Secondary

Type of App Usage - Exercises Completed

Frequency and duration of app use

Time frame: 3 months post-randomisation

Population: Participants assigned to Wysa intervention group; data from some participants was missing if they did not use that feature.

ArmMeasureValue (MEAN)Dispersion
Wysa AI Chatbot Mental Health AppType of App Usage - Exercises Completed7.11 Exercises completedStandard Deviation 7.79
Secondary

Type of App Usage - Messages to Chatbot

Frequency and duration of app use

Time frame: 3 months post-randomisation

Population: Participants assigned to Wysa intervention group; data from some participants was missing if they did not use that feature.

ArmMeasureValue (MEAN)Dispersion
Wysa AI Chatbot Mental Health AppType of App Usage - Messages to Chatbot227 Messages to chatbotStandard Deviation 319
Secondary

Type of App Usage - Sessions Completed

Frequency and duration of app use

Time frame: 3 months post-randomisation

Population: Participants assigned to Wysa intervention group; data from some participants was missing if they did not use that feature.

ArmMeasureValue (MEAN)Dispersion
Wysa AI Chatbot Mental Health AppType of App Usage - Sessions Completed24.3 Sessions completedStandard Deviation 29.8
Secondary

Uptake Rates

Uptake rates of participants randomised into intervention group

Time frame: 3 months post-randomisation

Population: Participants randomly assigned to intervention group

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Wysa AI Chatbot Mental Health AppUptake Rates30 Participants
Waitlist ControlUptake Rates16 Participants
Secondary

Use of the App

Participant engagement with the app (whether it was used at all based on app usage data)

Time frame: 3-7 months post-randomisation

Population: Participants assigned to Wysa group

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Wysa AI Chatbot Mental Health AppUse of the AppEngaged with Wysa18 Participants
Wysa AI Chatbot Mental Health AppUse of the AppDid not engage with Wysa12 Participants

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026